How to Set Up a Stem Cell Laboratory
A practical guide to planning, designing, equipping, and commissioning a stem cell laboratory with clearer readiness decisions from day one.
Practical guides for stem cell laboratory planning, GMP readiness, R&D coordination, and evidence-aware review of clinic or study claims without drifting into unsupported treatment promises.
These guides support enterprise consulting and individual advisory without drifting away from the core consulting model.
A practical guide to planning, designing, equipping, and commissioning a stem cell laboratory with clearer readiness decisions from day one.
A practical checklist for core cell-culture equipment, molecular biology support, QC, cryostorage, monitoring, records, and GMP-readiness planning.
A practical guide to quarantine, aseptic technique, mycoplasma testing, response steps, and cell-culture quality habits.
An evidence-based checklist for building proportionate document control, training, supplier, deviation, CAPA, and change-control habits before GMP pressure arrives.
How to connect mechanism-of-action logic, assay selection, process controls, quality risk, and GMP-readiness.
A plain comparison of discovery laboratories and GMP facilities, including documentation, traceability, quality oversight, and transition planning.
How to align exploratory science, documentation discipline, milestone ownership, and reviewable handoffs as a regenerative medicine program starts to scale.
A practical guide to the difference between FDA approval, ClinicalTrials.gov registration, NCT numbers, study listings, and clinic claims.
A practical framework for comparing study design, endpoints, controls, registration, limitations, and relevance to clinic claims.
A practical guide to reading NCT records, sponsors, study status, eligibility criteria, endpoints, and results without mistaking registration for approval.
A scientific advisory guide to exosome marketing, FDA approval language, product identity, evidence matching, and provider questions.
A science-first checklist for interpreting clinic claims, study references, and treatment language more critically before provider conversations.
An FDA- and ISSCR-aligned checklist for spotting broad treatment claims, weak evidence matching, and language that needs direct clinician clarification.
Use the service page that matches your decision context, or go directly to booking when the question is already well formed.